Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users.

Back-Madruga C, Boone KB, Chang L, Grob CS, Lee A, Nations H, Poland RE.

Clin Neuropsychol. 2003 Nov;17(4):446-59.

PMID:
15168910
2.

Syllogistic reasoning performance in MDMA (Ecstasy) users.

Montgomery C, Fisk JE, Newcombe R, Wareing M, Murphy PN.

Exp Clin Psychopharmacol. 2005 May;13(2):137-45.

PMID:
15943546
3.

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.

Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.

J Psychopharmacol. 2006 Mar;20(2):211-25. Review.

PMID:
16510479
4.

The harmful health effects of recreational ecstasy: a systematic review of observational evidence.

Rogers G, Elston J, Garside R, Roome C, Taylor R, Younger P, Zawada A, Somerville M.

Health Technol Assess. 2009 Jan;13(6):iii-iv, ix-xii, 1-315. doi: 10.3310/hta13050. Review.

5.
6.

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

Parrott AC, Lasky J.

Psychopharmacology (Berl). 1998 Oct;139(3):261-8.

PMID:
9784083
7.

Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence.

Dafters RI, Duffy F, O'Donnell PJ, Bouquet C.

Psychopharmacology (Berl). 1999 Jul;145(1):82-90.

PMID:
10445376
8.

Cognitive performance amongst recreational users of "ecstasy".

Rodgers J.

Psychopharmacology (Berl). 2000 Jul;151(1):19-24.

PMID:
10958112
9.

Memory deficits associated with recreational use of "ecstasy" (MDMA).

Morgan MJ.

Psychopharmacology (Berl). 1999 Jan;141(1):30-6.

PMID:
9952062
10.

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study.

McCann UD, Mertl M, Eligulashvili V, Ricaurte GA.

Psychopharmacology (Berl). 1999 Apr;143(4):417-25.

PMID:
10367560
11.

Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs.

Halpern JH, Pope HG Jr, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd D.

Drug Alcohol Depend. 2004 Aug 16;75(2):135-47.

PMID:
15276218
12.

The relative contributions of ecstasy and cannabis to cognitive impairment.

Croft RJ, Mackay AJ, Mills AT, Gruzelier JG.

Psychopharmacology (Berl). 2001 Jan;153(3):373-9.

PMID:
11271410
13.

The neuropsychology of ecstasy (MDMA) use: a quantitative review.

Zakzanis KK, Campbell Z, Jovanovski D.

Hum Psychopharmacol. 2007 Oct;22(7):427-35. Review.

PMID:
17896346
14.

Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study.

de Sola S, Tarancón T, Peña-Casanova J, Espadaler JM, Langohr K, Poudevida S, Farré M, Verdejo-García A, de la Torre R.

Psychopharmacology (Berl). 2008 Oct;200(3):425-37. doi: 10.1007/s00213-008-1217-5. Epub 2008 Jun 26.

PMID:
18581098
15.

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HJ, Fimm B, Sass H.

J Neurol Neurosurg Psychiatry. 2000 Jun;68(6):719-25.

16.

Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.

Gouzoulis-Mayfrank E, Fischermann T, Rezk M, Thimm B, Hensen G, Daumann J.

Drug Alcohol Depend. 2005 Jun 1;78(3):317-23. Epub 2005 Jan 19.

PMID:
15893163
17.

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

Morgan MJ, McFie L, Fleetwood H, Robinson JA.

Psychopharmacology (Berl). 2002 Jan;159(3):294-303. Epub 2001 Oct 12.

PMID:
11862362
18.

Memory impairment in abstinent MDMA ("Ecstasy") users.

Bolla KI, McCann UD, Ricaurte GA.

Neurology. 1998 Dec;51(6):1532-7.

PMID:
9855498
19.

Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.

Parrott AC, Lees A, Garnham NJ, Jones M, Wesnes K.

J Psychopharmacol. 1998;12(1):79-83.

PMID:
9584971
20.

Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.

Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O.

J Psychopharmacol. 2006 May;20(3):389-99.

PMID:
16574713

Supplemental Content

Support Center